DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bettiol A, Pregnolato F, Sciascia S, Emmi G, Prisco D, Meroni PL.
Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al.
Ann Rheum Dis 2020;
DOI: 10.1136/annrheumdis-2020-218377.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.